Here are five things Mr. Whitaker said about device tax repeal:
1. “The good news is that in this bill, whether you like the insurance reforms or dislike the insurance reforms, from a med-tech perspective there’s almost unanimity that the device tax should be repealed.”
2. “Bipartisan support for that, you don’t have any Democrats who are opposed to it, based on what I can tell, and all Republicans are lined up in support of it as well.”
3. “If the healthcare bill falls apart, we’ve already been communicating with members of Congress and leadership that we need to take that [medtech tax repeal] provision, pull it out of that bill and pin it to the next moving vehicle.”
4. “I’ve been told by everybody, including leadership in the House and the Senate, one way or the other we’ll get it done this year.”
5. “With the uncertainty of whether device tax is going to come back on your books or go off the books, it’s hard to make investment decisions both in the short term and in the long term.”
More articles on devices:
Global bone growth stimulators market — Spinal fusion segment led in 2016
Mayfield Brain & Spine implants 1st Senza SCS system in region — 5 highlights
Xtant Medical reports $22.1M in revenue for Q1 2017 — 10 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
